Excess fatality from desipramine in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 1, 2006, Pages 54-60

  Amitai, Yona ^a   Frischer, Henri ^b  

^a MINISTRY OF HEALTH   (Israel)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Desipramine; Fatality; Ingestion; Toxicity

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; DOXEPIN; IMIPRAMINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DRUG FATALITY; EPIDEMIOLOGICAL DATA; FATALITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

EID: 29144461660     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000184931.26176.4a     Document Type: Article

References (43)

1. Abramowicz, M (1990), Sudden death in children treated with a tricyclic antidepressant. Med Lett Drugs Ther 32:53
2. Amitai Y (2001), Establishing a cause of death dependent upon time of postmortem. J Toxicol Clin Toxicol 39:651-652
3. Amitai Y, Frischer H (1994), The toxicity and dose of desipramine hydrochloride. JAMA 272:1719-1720
4. Amitai Y, Frischer H (2004), Excess fatality from desipramine and dosage recommendations. Ther Drug Monit 26:468-473
5. Bar-Oz B, Levichek Z, Koren G (2004), Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Pediatr Drugs 6:123-126
6. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A (1989), A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
7. Biederman J, Thisted RA, Greenhill LL, Ryan ND (1995), Estimation of the association between desipramine and the risk for sudden death in 5 to 14 year old children. J Clin Psychiatry 56:87-93
8. Buckley NA, McManus PR (1998), Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data? Drug Saf 18:369-381
9. Cassidy S. Henry J (1997), Fatal toxicity of antidepressant drugs in overdose. BMJ 295:1021-1024
10. Delate T, Gelenberg AJ, Simmons VA, Motheral BR (2004), Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv 55:387-391
11. Greenhill LL, Vitiello B, Abikoff H et al. (2003), Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 5, 2000. J Am Acad Child Adolesc Psychiatry 42:651-655
12. Henry JA, Alexander CA, Sener EK (1995), Relative toxicity from overdose of antidepressants. BMJ 310:221-224
13. Hope-Roberts JM, Lloyd LM, Chyka PA (2000), Poisoning mortality in the United States: comparison of national mortality statistics and poison control reports. Ann Emerg Med 35:440-448
14. Kapur S, Mieczkowski T, Mann J (1992), Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 268:3441-3445
15. Litovitz T, Veltri JC (1985), 1984 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 3:423-450
16. Litovitz TL, Normann SA, Veltri JC (1986), 1985 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 4:427-458
17. Litovitz TL, Martin TG, Schmitz B (1987), 1986 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 5:405-445
18. Litovitz TL, Schmitz B, Matyunas N, Martin TG (1988), 1987 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 6:479-515
19. Litovitz TL, Schmitz B, Holm KC (1989), 1988 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 7:495-545
20. Litovitz TL, Schmitz B, Bailey KM (1990), 1989 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 8:394-442
21. Litovitz TL, Bailey KM, Schmitz B, Holm KC, Klein-Schwartz W (1991), 1990 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 9:461-509
22. Litovitz TL, Holm KC, Bailey KM, Schmitz BF (1992), 1991 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 10:452-505
23. Litovitz TL, Holm KC, Clancy C, Schmitz B, Clark LR, Oderda GM (1993), 1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 11:494-555
24. Litovitz TL, Clark LR, Soloway RA (1994), 1993 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 12:546-584
25. Litovitz TL, Felberg L, Soloway RA, Ford M, Geller R (1995), 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 13:551-597
26. Litovitz TL, Felberg L, White S, Klein-Schwartz W (1996), 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 14:487-537
27. Litovitz TL, Smilkstein M, Felberg L, Klein-Schwartz W, Berlin R, Morgan JL (1997), 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 15:447-500
28. Litovitz TL, Dyer KS, Shannon M, Lee S, Powers M (1998), 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 16:443-497
29. Litovitz TL, Klein-Schwartz W, Caravati EM, Youniss J, Crouch B, Lee S (1999), 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 17:435-487
30. Litovitz TL, Klein-Schwartz W, White S et al. (2000), 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 18:517-574
31. Litovitz TL, Klein-Schwartz W, White S et al. (2001), 2000 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 19:337-395
32. Litovitz TL, Klein-Schwartz W, Cobaugh DJ et al. (2002), 2001 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20:391-452
33. Love JN, Litovitz TL, Howell JM, Clancy C (1997), Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. J Toxicol Clin Toxicol 35:353-359
34. Riddle MA, Nelson C, Kleinman CS et al. (1991), Sudden death in children receiving Norpramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30:104-108
35. Riddle MA, Geller B, Ryan N (1993), Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:792-797
36. Rose JC, Unis AS (2000), A mortality index for post marketing surveillance of new medications. Am J Emerg Med 18:176-179
37. Varley CK (2001), Sudden deaths related to selected tricyclic antidepressants in children. Pediatr Drugs 3:613-627
38. Veltri JC, Litovitz TL (1984), 1983 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 2:420-443
39. Vitiello B, Riddle MA, Greenhill LL et al. (2003), How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry 42:634-641
40. Waslick BD, Walsh BT, Greenhill LL et al. (1999), Cardiovascular effects of desipramine in children and adults during exercise testing. J Am Acad Child Adolesc Psychiatry 38:179-186
41. Watson WA, Litovitz TL, Rodgers GC Jr et al. (2003), 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21:353-421
42. Werry HS, Biederman J, Thisted R, Greenhill L, Ryan N (1995), Debate forum. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children. J Am Acad Child Adolesc Psychiatry 34:1239-1248
43. Work Group on Research and Office of Research, AACAP (1992). Desipramine (DMI) and sudden death. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, October 23